Benin Management Corp’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $352K | Hold |
4,076
| – | – | 0.07% | 111 |
|
|
2026
Q2 | $369K | Sell |
4,076
-200
| -5% | -$16.8K | 0.07% | 114 |
|
|
2026
Q1 | $342K | Hold |
4,276
| – | – | 0.08% | 106 |
|
|
2025
Q4 | $365K | Sell |
4,276
-500
| -10% | -$41K | 0.08% | 101 |
|
|
2025
Q3 | $371K | Hold |
4,776
| – | – | 0.09% | 96 |
|
|
2025
Q2 | $374K | Hold |
4,776
| – | – | 0.1% | 91 |
|
|
2025
Q1 | $346K | Buy |
4,776
+33
| +0.7% | +$2.36K | 0.1% | 91 |
|
|
2024
Q4 | $351K | Hold |
4,743
| – | – | 0.1% | 89 |
|
|
2024
Q3 | $313K | Sell |
4,743
-350
| -7% | -$25.4K | 0.09% | 97 |
|
|
2024
Q2 | $470K | Buy |
5,093
+43
| +0.9% | +$3.81K | 0.14% | 74 |
|
|
2024
Q1 | $483K | Sell |
5,050
-6
| -0.1% | -$504 | 0.15% | 66 |
|
|
2023
Q4 | $386K | Sell |
5,056
-1,344
| -21% | -$93.5K | 0.13% | 73 |
|
|
2023
Q3 | $443K | Hold |
6,400
| – | – | 0.16% | 62 |
|
|
2023
Q2 | $604K | Sell |
6,400
-1,500
| -19% | -$130K | 0.22% | 55 |
|
|
2023
Q1 | $654K | Hold |
7,900
| – | – | 0.25% | 51 |
|
|
2022
Q4 | $589K | Buy |
7,900
+5,400
| +216% | +$416K | 0.24% | 53 |
|
|
2022
Q3 | $207K | Hold |
2,500
| – | – | 0.09% | 89 |
|
|
2022
Q2 | $238K | Buy |
2,500
+700
| +39% | +$72.5K | 0.09% | 88 |
|
|
2022
Q1 | $212K | Sell |
1,800
-2,800
| -61% | -$314K | 0.07% | 101 |
|
|
2021
Q4 | $596K | Hold |
4,600
| – | – | 0.18% | 66 |
|
|
2021
Q3 | $521K | Sell |
4,600
-2,400
| -34% | -$274K | 0.17% | 68 |
|
|
2021
Q2 | $725K | Sell |
7,000
-100
| -1% | -$9.43K | 0.23% | 53 |
|
|
2021
Q1 | $594K | Buy |
7,100
+3,700
| +109% | +$313K | 0.21% | 56 |
|
|
2020
Q4 | $310K | Buy |
+3,400
| New | +$282K | 0.12% | 77 |
|
|
2018
Q1 | – | Sell |
-15,900
| Closed | -$597K | – | 95 |
|
|
2017
Q4 | $597K | Hold |
15,900
| – | – | 0.24% | 56 |
|
|
2017
Q3 | $579K | Hold |
15,900
| – | – | 0.23% | 56 |
|
|
2017
Q2 | $627K | Hold |
15,900
| – | – | 0.27% | 50 |
|
|
2017
Q1 | $499K | Hold |
15,900
| – | – | 0.23% | 60 |
|
|
2016
Q4 | $497K | Buy |
15,900
+1,500
| +10% | +$48.6K | 0.23% | 62 |
|
|
2016
Q3 | $579K | Hold |
14,400
| – | – | 0.28% | 53 |
|
|
2016
Q2 | $479K | Hold |
14,400
| – | – | 0.25% | 64 |
|
|
2016
Q1 | $423K | Hold |
14,400
| – | – | 0.23% | 64 |
|
|
2015
Q4 | $379K | Hold |
14,400
| – | – | 0.21% | 64 |
|
|
2015
Q3 | $341K | Hold |
14,400
| – | – | 0.19% | 70 |
|
|
2015
Q2 | $342K | Hold |
14,400
| – | – | 0.18% | 71 |
|
|
2015
Q1 | $342K | Hold |
14,400
| – | – | 0.18% | 72 |
|
|
2014
Q4 | $306K | Sell |
14,400
-12,300
| -46% | -$247K | 0.16% | 77 |
|
|
2014
Q3 | $455K | Sell |
26,700
-28,800
| -52% | -$455K | 0.23% | 64 |
|
|
2014
Q2 | $794K | Sell |
55,500
-19,200
| -26% | -$260K | 0.43% | 45 |
|
|
2014
Q1 | $923K | Sell |
74,700
-6,660
| -8% | -$76.8K | 0.56% | 37 |
|
|
2013
Q4 | $892K | Sell |
81,360
-36,600
| -31% | -$413K | 0.56% | 42 |
|
|
2013
Q3 | $1.37M | Buy |
117,960
+57,960
| +97% | +$678K | 0.84% | 31 |
|
|
2013
Q2 | $672K | Buy |
+60,000
| New | +$710K | 0.41% | 49 |
|
Other funds holding EW
Benin Management Corp's EW Position: Q3 2026 in Review
Benin Management Corp held its Edwards Lifesciences (EW) position steady in Q3 2026 at 4,076 shares worth $352K. The position accounts for 0.07% of the portfolio, ranked #111.
Benin Management Corp first reported a position in EW in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.37M in Q3 2013. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Benin Management Corp held 4,076 shares of Edwards Lifesciences worth $352K as of Q3 2026.
- Benin Management Corp left its Edwards Lifesciences share count unchanged in Q3 2026.
- Edwards Lifesciences made up 0.07% of Benin Management Corp's portfolio in Q3 2026, its #111 holding.
- Benin Management Corp first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 43 quarters since.
- Benin Management Corp's Edwards Lifesciences position peaked at $1.37M in Q3 2013.
- 326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Benin Management Corp's 13F filing for Q3 2026, filed 22 Oct 2026.